Premium
Neuroleptic malignant syndrome in a patient with acquired immunodeficiency syndrome
Author(s) -
Bernstein W. B.,
Scherokman B.
Publication year - 1986
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1986.tb04612.x
Subject(s) - neuroleptic malignant syndrome , haloperidol , medicine , prochlorperazine , serotonin syndrome , anesthesia , creatine kinase , serotonin , dopamine , receptor , serotonergic , nausea
A patient with acquired immunodeficiency syndrome treated with prochlor‐perazine and droperidol developed neuroleptic malignant syndrome, characterized by akinetic mutism, resting tremor, cogwheel rigidity, and elevated serum creatine phosphokinase. An identical syndrome reappeared with subsequent administration of haloperidol. Neuroleptic malignant syndrome has not been previously reported in acquired immunodeficiency syndrome.